The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Klinkova A.S.

Meshalkin National Medical Research Center

Kamenskaya O.V.

Meshalkin National Medical Research Center

Loginova I.Yu.

Meshalkin National Medical Research Center

Porotnikova S.S.

Meshalkin National Medical Research Center

Lomivorotov V.N.

Meshalkin National Medical Research Center

Chernyavskiy A.M.

National Medical Research Center

Lomivorotov V.V.

Meshalkin National Medical Research Center;
Novosibirsk State University

Features of psychoemotional status in patients with chronic thromboembolic pulmonary hypertension after cardiac surgery during the COVID-19 pandemic

Authors:

Klinkova A.S., Kamenskaya O.V., Loginova I.Yu., Porotnikova S.S., Lomivorotov V.N., Chernyavskiy A.M., Lomivorotov V.V.

More about the authors

Read: 3163 times


To cite this article:

Klinkova AS, Kamenskaya OV, Loginova IYu, Porotnikova SS, Lomivorotov VN, Chernyavskiy AM, Lomivorotov VV. Features of psychoemotional status in patients with chronic thromboembolic pulmonary hypertension after cardiac surgery during the COVID-19 pandemic. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(8):80‑87. (In Russ.)
https://doi.org/10.17116/jnevro202212208180

Recommended articles:
Pathogenetic inte­rrelations of hypo­gonadism and depression in men. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):17-23
Asthenia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):5-10
Factors of depression acco­rding to acti­graphy in the fall season. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):27-32
Identification of depression biomarkers: Prospects for use in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):51-55
Depression Anxiety Stress Scale (russian language version). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):103-107

References:

  1. Abritalin EY. About the causes and therapy of depressive disorders in COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry =Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2021;121(8):87-92. (In Russ.). https://doi.org/10.17116/jnevro202112108187
  2. Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Research. 2020;288:112954. https://doi.org/10.1016/j.psychres.2020.112954
  3. Stein MB. COVID‐19 and Anxiety and Depression in 2020. Depression and Anxiety. 2020;37(4):302-302.  https://doi.org/10.1002/da.23014
  4. Li W, Yang Y, Liu Z-H, et al. Progression of Mental Health Services during the COVID-19 Outbreak in China. International Journal of Biological Sciences. 2020;16(10):1732-1738. https://doi.org/10.7150/ijbs.45120
  5. Bubnova MG, Aronov DM. COVID-19 and cardiovascular diseases: from epidemiology to rehabilitation. Pul’monologiya. 2020;30(5):688-699. (In Russ.). https://doi.org/10.18093/0869-0189-2020-30-5-688-699
  6. Zhou X, Shi H, Yang Y, et al. Anxiety and depression in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a Chinese survey. Experimental and Therapeutic Medicine. 2020;12(6):23-29.  https://doi.org/10.3892/etm.2020.8566
  7. Kamenskaya O, Klinkova A, Chernyavskiy A, et al. Long-term health-related quality of life after surgery in patients with chronic thromboembolic pulmonary hypertension. Quality of Life Research. 2020;29(8):2111-2118. https://doi.org/10.1007/s11136-020-02471-z
  8. Beck AT. An Inventory for Measuring Depression. Archives of General Psychiatry. 1961;4(6):561.  https://doi.org/10.1001/archpsyc.1961.01710120031004
  9. https://www.psycabi.net/testy/592-shkala-test-oprosnik-depressii-beka-kognitivnaya-terapiya-beka-ili-kak-vyjti-iz-depressii
  10. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A Brief Measure for Assessing Generalized Anxiety Disorder. Archives of Internal Medicine. 2006;166(10):1092. https://doi.org/10.1001/archinte.166.10.1092
  11. Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:136.  https://doi.org/10.1136/bmj.n136
  12. Klok FA, Boon GJAM, Barco S, et al. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. European Respiratory Journal. 2020;56(1):2001494. https://doi.org/10.1183/13993003.01494-2020
  13. Belotserkovskaya YuG, Romanovskikh AG, Smirnov IP, Sinopalnikov AI. Long COVID-19. Consilium Medicum. 2021;23(3):261-268. (In Russ.). https://doi.org/10.26442/20751753.2021.3.200805
  14. Ostroumova OD, Goloborodova IV, Fomina VM, Bondarets OV. Anxiety and depressive disorders in ardiology practice. Possibilities of using D,L-gopantenic acid. Consilium Medicum. 2018;20(12). (In Russ.). https://doi.org/10.26442/20751753.2018.12.000032
  15. Samushiya MA, Kryzhanovsky SM, Ragimova AA, Berishvili TZ, Chorbinskaya SA, Ivannikova EI. COVID-19 effect on mental health and sleep disorders. S.S. Korsakov Journal of Neurology and Psychiatry =Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2021;121(4 vyp 2):49-54. (In Russ.). https://doi.org/10.17116/jnevro202112104249
  16. Khramov EV, Ivanov VS. Modern foreign studies of depressive disorders during the COVID-19 pandemic. Sovremennaya zarubezhnaya psikhologiya =Journal of Modern Foreign Psychology. 2021;10(1):39-47. (In Russ.). https://doi.org/10.17759/jmfp.2021100104
  17. Petrova NN, Savickaya KS. The diagnosis and therapy of comorbid anxiety and depression disorders in clinical practice. V.M. Bekhterev review of psychiatry and medical psychology. 2021;1:102-112. (In Russ.). https://doi.org/10.31363/2313-7053-2021-1-102-112
  18. Tang M, Wang S-H, Li H-L, et al. Mental health status and quality of life in elderly patients with coronary heart disease. Peer J. 2021;9:e10903. https://doi.org/10.7717/peerj.10903
  19. Bogolepova AN. Vascular depression and cognitive dysfunction. Nevrologiya, neiropsikhiatriya, psikhosomatika =Neurology, Neuropsychiatry, Psychosomatics. 2019;11(suppl 3):26-31. (In Russ.). https://doi.org/10.14412/2074-2711-2019-3S-26-31
  20. Shuteeva TV. Modern approaches to the correction of cognitive and emotional disorders in patients with chronic cerebral ischemia. RMJ. 2017;21:1507-1510. (In Russ.). https://www.rmj.ru/articles/nevrologiya/Sovremennye_predstavleniya_o_terapii_trevoghnodepressivnyh_rasstroystv_pri_hronicheskoy_ishemii_golovnogo_mozga/#ixzz7OKYHOU6V
  21. Carod-Artal FJ. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol. 2021;72(11):384-396. (English, Spanish). https://doi.org/10.33588/rn.7211.2021230

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.